TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24646165

Group type: EXPERIMENTAL
Intervention: Intervention with single contact
Number of subjects: 4676

Group type: EXPERIMENTAL
Intervention: Intervention with dual contact
Number of subjects: 4676

Group type: COMPARATOR
Intervention: Control with single contact
Number of subjects: 4676

Group type: COMPARATOR
Intervention: Control with dual contact
Number of subjects: 4676

Group type: EXPERIMENTAL
Intervention: Intervention groups (single and dual contact)
Number of subjects: 4676

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 4676
Study: 23286405

Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 275

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 275

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 275
Study: 19630068

Group type: EXPERIMENTAL
Intervention: Cognitive Therapy (CT)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Interpersonal Therapy
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cognitive factor estimated cost
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Cognitive factor estimated cost and treatment
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Pre-treatment use of anxiolytics
Number of subjects: 77
Study: 17645261

Group type: EXPERIMENTAL
Intervention: Combined TCM and western medicine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: TCM
Number of subjects: 90

Group type: COMPARATOR
Intervention: Western medicine
Number of subjects: 90
Study: 16286871

Group type: EXPERIMENTAL
Intervention: 25 g of whey and caseinate proteins (PROT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Noncaloric placebo (P)
Number of subjects: 10
Study: 12077712

Group type: EXPERIMENTAL
Intervention: HLA-DRB1*0301-DQB1*0201 haplotype
Number of subjects: 73
Study: 9862605

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crossover to alternative medication
Number of subjects: 0
Study: 8548054

Group type: EXPERIMENTAL
Intervention: Melatonin (100 mg)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 2296932

Group type: EXPERIMENTAL
Intervention: 10 mg daily oral folic acid supplement (F group)
Number of subjects: 245

Group type: COMPARATOR
Intervention: Placebo (P group)
Number of subjects: 245
Study: 6968153

Group type: EXPERIMENTAL
Intervention: Anticoagulant or antiplatelet therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no antithrombotic therapy)
Number of subjects: 0
Study: 31055526

Group type: EXPERIMENTAL
Intervention: Normal body mass with expressed endogenous intoxication syndrome
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Normal body mass with minimum degree of endogenous intoxication
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Increased level of blood medium-weight molecules (MWM254)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Combination of hypoleptinemia with severe endogenous intoxication
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Evaluation of leptin level
Number of subjects: 58
Study: 27617694

Group type: EXPERIMENTAL
Intervention: SwimOnly
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: SwimDry
Number of subjects: 13

Group type: COMPARATOR
Intervention: NoEx
Number of subjects: 13
Study: 25879452

Group type: EXPERIMENTAL
Intervention: Isolated hip strengthening
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Quadriceps-based training
Number of subjects: 150

Group type: COMPARATOR
Intervention: Free physical activity (Control)
Number of subjects: 150
Study: 24025260

Group type: EXPERIMENTAL
Intervention: 12-week intensive exercise program for the whole body (including locomotor training, trunk exercises, and functional electrical stimulation-assisted cycling)
Number of subjects: 188

Group type: COMPARATOR
Intervention: 12-week intensive upper body exercise program
Number of subjects: 188
Study: 21412146

Group type: EXPERIMENTAL
Intervention: Open insertion technique performed by surgeons
Number of subjects: 110

Group type: COMPARATOR
Intervention: Puncture of the subclavian vein under fluoroscopic guidance by radiologists
Number of subjects: 110
Study: 19626360

Group type: EXPERIMENTAL
Intervention: Frozen nasogastric tube (NGT)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard nasogastric tube (control)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (frozen and control)
Number of subjects: 100
Study: 19160425

Group type: EXPERIMENTAL
Intervention: Video rigid laryngoscopy (VRL)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Laryngeal mirror examination (LME)
Number of subjects: 43
Study: 16365887

Group type: EXPERIMENTAL
Intervention: ThermaCool device (one treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ThermaCool device (two treatments)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: ThermaCool device (one and two treatments)
Number of subjects: 10
Study: 12068188

Group type: EXPERIMENTAL
Intervention: Sigmoid J-pouch
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Descending J-pouch
Number of subjects: 92
Study: 9678146

Group type: EXPERIMENTAL
Intervention: Famciclovir
Number of subjects: 0
Study: 8820528

Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 0

Group type: COMPARATOR
Intervention: Antidepressant treatment
Number of subjects: 0
Study: 2242492

Group type: EXPERIMENTAL
Intervention: Synthetic salmon calcitonin (sCT) 100 MRC U injected i.m. every other day for 12 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo injection for the first 6 months, followed by sCT 100 MRC U injected i.m. every other day for the next 6 months
Number of subjects: 0
Study: 358766

Group type: EXPERIMENTAL
Intervention: Increased dose of lidocaine (bolus dose 50 mg followed by infusion 3 mg/min)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: QX-572 (600 mg N,N‐bis dimethylammonium chloride) as an i.v. infusion during 30 min or 60 min
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (standard lidocaine therapy)
Number of subjects: 31
Study: 12474611

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0
Study: 31332914

Group type: EXPERIMENTAL
Intervention: Physical activity counselling (three sessions at 1, 4, and 8 weeks; three telephone follow-ups over 13 weeks)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Physical activity counselling
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study: 30015059

Group type: EXPERIMENTAL
Intervention: General laryngeal mask airway (LMA) anesthesia with lumbar plexus-sciatic nerve block (LPSB)
Number of subjects: 63

Group type: COMPARATOR
Intervention: General anesthesia with endotracheal intubation (ET)
Number of subjects: 63
Study: 26140543

Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Copper intrauterine device (Cu-IUD)
Number of subjects: 56
Study: 24802206

Group type: EXPERIMENTAL
Intervention: Intensified Conventional Treatment (ICT)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Standard Treatment (ST)
Number of subjects: 72
Study: 22499718

Group type: EXPERIMENTAL
Intervention: Ginseng (G)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ginseng + Exercise (G+Ex)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (C)
Number of subjects: 52
Study: 19776738

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP)
Number of subjects: 98
Study: 19230172

Group type: EXPERIMENTAL
Intervention: cilazapril 10 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: cilazapril 5 mg
Number of subjects: 18
Study: 15981759

Group type: EXPERIMENTAL
Intervention: Asthma clinical pathway implementation
Number of subjects: 270

Group type: COMPARATOR
Intervention: Usual asthma medical care management (Control)
Number of subjects: 270

Group type: COMPARATOR
Intervention: General practitioners not participating in the trial
Number of subjects: 270
Study: 12114383

Group type: EXPERIMENTAL
Intervention: Methacholine bronchial provocation
Number of subjects: 22

Group type: COMPARATOR
Intervention: Eucapnic hyperventilation of dry air
Number of subjects: 22
Study: 9931211

Group type: EXPERIMENTAL
Intervention: Oxygen via face mask at 12 l/min (group C)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Oxygen via nasal prongs at 5 l/min (group B)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Room air (group A)
Number of subjects: 22
Study: 7844680

Group type: EXPERIMENTAL
Intervention: Parenteral L-carnitine supplementation (50 mumol/kg per day)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Parenteral L-carnitine supplementation
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (no carnitine supplementation)
Number of subjects: 43
Study: 2190462

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN), 120 mg once daily
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nifedipine, 20 mg twice daily
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 348614

Group type: EXPERIMENTAL
Intervention: N‐Amidino‐2‐(2,6‐dichlorophenyl) acetamide hydrochloride (BS 100‐‐141)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Clonidine
Number of subjects: 16
Study: 29415600

Group type: EXPERIMENTAL
Intervention: Patients with adhesions
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Patients with adhesion score three
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Adhesion severity score
Number of subjects: 97
Study: 30113644

Group type: EXPERIMENTAL
Intervention: Personal noise exposure measurements (8 h) using dosimeters
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Area noise measurements (10-s measurements) using a sound level meter
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Determinants of noise exposure in the furnace section
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Determinants of noise exposure in the rolling mill section
Number of subjects: 163
Study: 25289713

Group type: EXPERIMENTAL
Intervention: RSA cycling
Number of subjects: 0

Group type: COMPARATOR
Intervention: RSA running
Number of subjects: 0
Study: 25402337

Group type: EXPERIMENTAL
Intervention: Home-based inductive reasoning training program
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Team-based competitive program in creative problem solving
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 0
Study: 22948944

Group type: EXPERIMENTAL
Intervention: High Saturated Fat (HSF) diet
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low Saturated Fat diet
Number of subjects: 14
Study: 20587541

Group type: EXPERIMENTAL
Intervention: Combination of UV‐A (25%), UV‐B (5%) and visible light (70%)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Low‐intensity visible light (Control)
Number of subjects: 79
Study: 17624203

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 mg, adjusted to 25 mg or 100 mg as needed)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 16264052

Group type: EXPERIMENTAL
Intervention: Modified Chrispin-Norman scoring system (CNS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Original Chrispin-Norman scoring system (CNS)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Modified CNS
Number of subjects: 50

Group type: COMPARATOR
Intervention: Original CNS
Number of subjects: 50
Study: 11228485

Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/d for 1 year
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 9604239

Group type: EXPERIMENTAL
Intervention: Pacing at the right ventricular outflow tract (RVOT)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Combined pacing at both RV sites (RVOT and RVA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Pacing at the RV apex (RVA)
Number of subjects: 14
Study: 7846210

Group type: EXPERIMENTAL
Intervention: Lorazepam (0.0, 0.06, 0.13, 0.25, 0.5 mg; total cumulative dose: 0.94 mg)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 3288775

Group type: EXPERIMENTAL
Intervention: 50 per cent dimethyl sulfoxide
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 33
Study: 31642331

Group type: EXPERIMENTAL
Intervention: Nomogram-based Cox proportional regression model using 9 biomarkers (Beclin 1, Aurora‐A, Cyclin D1, Ki‐67, P27, Bcl‐2, MMP‐9, 14‐3‐3σ, VCA‐IgA)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Nomogram algorithm for individual metastasis risk
Number of subjects: 147
Study: 28448477

Group type: EXPERIMENTAL
Intervention: Gelatin tannate plus ORS
Number of subjects: 203
Study: 26437529

Group type: EXPERIMENTAL
Intervention: Aromatic therapy using menthol
Number of subjects: 317

Group type: COMPARATOR
Intervention: Non-menthol group (control)
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Both groups (menthol and non-menthol)
Number of subjects: 317
Study: 23400584

Group type: EXPERIMENTAL
Intervention: Access to the complete ultrasound module
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group with access to only the lumbar anatomy module
Number of subjects: 16
Study: 21468614

Group type: EXPERIMENTAL
Intervention: Magnesium sulphate (500 mg in 20 ml saline)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Levobupivacaine (100 mg in 20 ml 0.5%)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Lornoxicam (8 mg in 20 ml saline)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (20 ml saline)
Number of subjects: 120
Study: 20027406

Group type: EXPERIMENTAL
Intervention: Midazolam 15 mg
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: COMPARATOR
Intervention: No medication
Number of subjects: 42
Study: 17037821

Group type: EXPERIMENTAL
Intervention: Tianeptine (37.5 mg/day)
Number of subjects: 298

Group type: COMPARATOR
Intervention: Fluvoxamine (100 mg/day)
Number of subjects: 298
Study: 14624184

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 18
Study: 11123496

Group type: EXPERIMENTAL
Intervention: Infusion devices prepared by pharmacy (5 days)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Reconstituted drugs by patients (5 days)
Number of subjects: 8
Study: 9499941

Group type: EXPERIMENTAL
Intervention: sphenoidal angle measurement
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: sphenoidal angle as an ageing criterion
Number of subjects: 330
Study: 7934445

Group type: EXPERIMENTAL
Intervention: Standard infant formula supplemented with Bifidobacterium bifidum and S thermophilus
Number of subjects: 55

Group type: COMPARATOR
Intervention: Standard infant formula (control)
Number of subjects: 55
Study: 3219525

Group type: EXPERIMENTAL
Intervention: Stapled J pouch
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sutured W pouch
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Both J pouch and W pouch
Number of subjects: 33
Study: 29154159

Group type: EXPERIMENTAL
Intervention: Brief Eclectic Psychotherapy for PTSD (BEP)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Eye Movement Desensitization and Reprocessing therapy (EMDR)
Number of subjects: 116
Study: 28760425

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (60 μg/d as selenious acid added to PN)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no selenium supplementation)
Number of subjects: 20
Study: 25695930

Group type: EXPERIMENTAL
Intervention: Intervention program to reduce quartz exposure
Number of subjects: 0
Study: 23731375

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg per day
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 400 mg per day
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 800 mg per day
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 200 mg per day, 400 mg per day, and 800 mg per day
Number of subjects: 171

Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 171
Study: 20090566

Group type: EXPERIMENTAL
Intervention: Beating-heart CPB
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Off-pump techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional CPB
Number of subjects: 0
Study: 18405821

Group type: EXPERIMENTAL
Intervention: Dental water jet (DWJ) with orthodontic jet tip plus manual toothbrush
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Flossing (FL) plus manual toothbrush
Number of subjects: 106

Group type: COMPARATOR
Intervention: Manual toothbrush (MT) only
Number of subjects: 106
Study: 16364710

Group type: EXPERIMENTAL
Intervention: Protein supplement (PRO, Myoplex, EAS, Inc. Golden CO) containing 280 kcal, 42 g protein, 21 g carbohydrate, and 1.5 g fat
Number of subjects: 52

Group type: COMPARATOR
Intervention: Calorically equivalent carbohydrate control (CS)
Number of subjects: 52
Study: 11933115

Group type: EXPERIMENTAL
Intervention: Polysaccharide fraction isolated from Echinacea purpurea (EPS‐EPO VIIa)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Historical control group (no intervention)
Number of subjects: 15
Study: 9457544

Group type: EXPERIMENTAL
Intervention: Self-reinforced poly-L-lactide (SR-PLLA) screws
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Metallic cannulated screws
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (nonoperated pairs)
Number of subjects: 21
Study: 8554733

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg daily)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 2151046

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 42

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 42
Study: 27546

Group type: EXPERIMENTAL
Intervention: Oxazepam
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Flurazepam
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Chloral hydrate
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 6127963

Group type: EXPERIMENTAL
Intervention: Intravenous theophyllamine (maximal mean plasma concentration of 16.7 +/- 1.21 micrograms/ml)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Inhaled terbutaline (five inhalations)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral theophylline (equipotent doses)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Oral terbutaline (equipotent doses)
Number of subjects: 6
Study: 31626158

Group type: EXPERIMENTAL
Intervention: Magnetophoretic diclofenac gel delivery using a traveling magnetic field (intensity, 20 mT; frequency, 6.25 Hz; exposure 20 min, 12 sessions)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo magnetotherapy with diclofenac without magnetic field
Number of subjects: 65

Group type: COMPARATOR
Intervention: Low-frequency pulse magnetotherapy with traveling magnetic field without topical diclofenac therapy
Number of subjects: 65
Study: 29380232

Group type: EXPERIMENTAL
Intervention: Prehypertension
Number of subjects: 2830

Group type: EXPERIMENTAL
Intervention: Hypertension
Number of subjects: 2830

Group type: EXPERIMENTAL
Intervention: High HbA1c (6.0-6.4%)
Number of subjects: 2830

Group type: EXPERIMENTAL
Intervention: Combined presence of hypertension and high HbA1c
Number of subjects: 2830

Group type: EXPERIMENTAL
Intervention: Systolic BP ≥ 130 mmHg
Number of subjects: 2830

Group type: EXPERIMENTAL
Intervention: Diastolic BP ≥ 80 mmHg
Number of subjects: 2830
Study: 26655582

Group type: EXPERIMENTAL
Intervention: Cold atmospheric plasma (CAP) applied for 90 seconds to a defined skin area of 22.5 cm(2)
Number of subjects: 20
Study: 24447503

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 28
Study: 22253252

Group type: COMPARATOR
Intervention: Hyaluronic Acid (HA)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Plasma (PRP)
Number of subjects: 32
Study: 20808257

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention combining electronic medical record based audit and feedback, practice site visits for academic detailing and participatory planning, and 'best-practice' dissemination
Number of subjects: 68150

Group type: COMPARATOR
Intervention: Control practices
Number of subjects: 68150

Group type: EXPERIMENTAL
Intervention: Quality improvement intervention
Number of subjects: 68150
Study: 17686440

Group type: EXPERIMENTAL
Intervention: Maintenance treatment with gemcitabine after first-line therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pemetrexed
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Erlotinib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adding bevacizumab to standard treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Platinum-based doublet with an additional cytotoxic agent
Number of subjects: 0
Study: 16300171

Group type: EXPERIMENTAL
Intervention: diclofenac potassium (HANA)
Number of subjects: 18

Group type: COMPARATOR
Intervention: diclofenac sodium (Shinpoong)
Number of subjects: 18
Study: 11981352

Group type: EXPERIMENTAL
Intervention: SRI plus quetiapine
Number of subjects: 27

Group type: COMPARATOR
Intervention: SRI plus placebo
Number of subjects: 27
Study: 9495269

Group type: EXPERIMENTAL
Intervention: Normal sodium diet
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Low sodium diet
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: High sodium diet
Number of subjects: 28
Study: 7696057

Group type: EXPERIMENTAL
Intervention: Continuous propofol and intermittent fentanyl (TIVA) with tracheal tube, neuromuscular blockers
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous propofol and intermittent fentanyl (TIVA) with tracheal tube, no neuromuscular blocker (Group 2)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous propofol and intermittent fentanyl (TIVA) with LMA, no neuromuscular blocker (Group 4)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Continuous propofol and intermittent fentanyl (TIVA) with LMA, neuromuscular blockers (Group 3)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Laryngeal mask airway (LMA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Tracheal tube
Number of subjects: 100
Study: 2654200

Group type: EXPERIMENTAL
Intervention: Desipramine 75 mg daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Desipramine 150 mg daily
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10